[1]程书立,柳彩侠*.早期高容量血液滤过治疗重症急性胰腺炎伴急性呼吸窘迫综合征疗效观察[J].徐州医科大学学报,2017,37(10):653-657.
　CHENG Shuli,LIU Caixia*.Effects of early high-volume hemofiltration on severe acute pancreatitis patients with respiratory distress syndrome[J].Journal of Xuzhou Medical University,2017,37(10):653-657.
点击复制

早期高容量血液滤过治疗重症急性胰腺炎伴急性呼吸窘迫综合征疗效观察()
分享到：

《徐州医科大学学报》[ISSN:2096-3882/CN:32-1875/R]

卷:
37
期数:
2017年10期
页码:
653-657
栏目:
出版日期:
2017-10-25

文章信息/Info

Title:
Effects of early high-volume hemofiltration on severe acute pancreatitis patients with respiratory distress syndrome
作者:
程书立1;  柳彩侠2*
1.徐州市中心医院重症医学科，江苏徐州221009；2.徐州医科大学附属医院肾内科，江苏徐州221002
Author(s):
CHENG Shuli1;  LIU Caixia2*
1.Department of Intensive Care Unit, Xuzhou Central Hospital, Xuzhou, Jiangsu 221009, China; 2.Department of Nephrology, the Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu 221002
关键词:
重症急性胰腺炎; 急性呼吸窘迫综合征;  早期高容量血液滤过; 炎症因子
Keywords:
severe acute pancreatitis;  acute respiratory distress syndrome;  early high-volume hemofiltration;  inflammatory factor
分类号:
R322.4+91
文献标志码:
A
摘要:
目的评价早期高容量血液滤过（HVHF）治疗重症急性胰腺炎（SAP）伴急性呼吸窘迫综合征（ARDS）患者的临床疗效。方法将入选的SAP伴有ARDS 的30例患者随机分为治疗组和对照组，每组15例。以机械通气（血液净化治疗开始）为起始点，分别于0、12、24、36、48、60、72 h 采集患者以下指标：肿瘤坏死因子α（TNF-α）、白细胞介素-10（IL-10）的浓度；呼吸频率、氧合指数、动脉血二氧化碳分压；急性生理与慢性健康评分（acute physiology and chronic health evaluationⅡ, APACHEⅡ）；并记录2组患者住院期间机械通气时间、ICU住院时间、总住院时间、住院病死率及28天病死率。结果①血液净化治疗后，治疗组患者IL-10、TNF-α浓度下降，与治疗前相比差异有统计学意义（P<0.05）；且在24 h及以后各时点IL-10、TNF-α浓度较对照组同一时间点下降（P<0.05）。②呼吸系统指标：治疗后2组患者氧合指数逐渐升高，治疗组患者在24 h后各时间点与对照组相比差异有统计学意义（P＜0.05）。2组患者的呼吸频率较治疗前均下降，治疗组下降显著，在60、72 h 2个时点与对照组相比差异有统计学意义（P＜0.05）。治疗组平均机械通气时间少于对照组（P＜0.05）。③APACHEⅡ评分：治疗后2组患者的APACHEⅡ评分均逐渐下降，治疗组改善明显，在12 h及以后各时间点APACHEⅡ评分低于对照组（P＜0.05）。④住院时间及病死率：治疗组ICU住院时间、总住院时间均少于对照组（P＜0.05）。治疗组患者住院病死率及28天病死率较对照组下降，但差异无统计学意义（P＞0.05）。结论早期高容量血液滤过可以清除SAP伴ARDS患者循环中炎症介质，改善患者的呼吸功能， 减轻患者病情， 减少ICU及总住院时间。
Abstract:
ObjectiveTo assess the efficacy of early high-volume hemofiltration (HVHF) on severe acute pancreatitis (SAP) patients with acute respiratory distress syndrome (ARDS). MethodsA total of 30 SAP patients with ARDS were enrolled into the study. The patients were randomly divided into a treatment group and a control group (n=15). With mechanical ventilation as the starting point, the levels of tumor necrosis factor α (TNF-α) and interleukin-10 (IL-10), and respiratory rate (RR), oxygenation index, arterial partial pressure of carbon dioxide, acute physiology and chronic health evaluation Ⅱ (APACHE Ⅱ) scores were measured on 0, 12, 24, 36, 48, 60 and 72 h. The time of mechanical ventilation, ICU and hospitalization stay, mortality in hospital and within 28 days were also recorded. ResultsAfter hemofiltration, the treatment group produced decreased levels of TNF-α and IL-10 compared with the levels before treatment (P<0.05) and those in the control group on 24, 36, 48, 60 and 72 h (P<0.05). After treatment, oxygenation index was increased in both groups compared with the levels before treatment, where the treatment group showed remarkably a higher oxygenation index than the control on 24, 36, 48, 60 and 72 h (P<0.05). After treatment, RR was decreased in both groups compared with the levels before treatment, where the treatment group showed remarkably lower RR than the control on 60 and 72 h (P<0.05). The time of mechanical ventilation was markedly shortened in the treatment group compared with the control (P<0.05). After treatment, APACHE Ⅱ was decreased in both groups compared with the levels before treatment, where the treatment group showed remarkably lower APACHE Ⅱ than the control on 12, 24, 36, 48, 60 and 72 h (P<0.05). Furthermore, the treatment group required shorter ICU and hospitalization stay than the control (P<0.05). However, no statistical difference was found as to mortality in hospital and within 28 days between the two groups (P>0.05). ConclusionsEarly HVHF can clear the inflammatory factors within the circulation of SAP patients with ARDS, improve the respiratory function, relieve the syndromes, and reduce ICU and hospitalization stay.

参考文献/References:

［1］Banks PA. Acute pancreatitis: medical and surgical management ［J］. Am J Gastroenterol, 1994,89(8 Suppl):S78-S85. ［2］张聪,蔡英丽,刘志兰,等.早期机械通气治疗重症急性胰腺炎的应用价值［J］. 中国基层医药,2016,23(11):1695-1699. ［3］邵斌霞,何斌,刘红梅,等.急性重症胰腺炎并发ARDS多因素回归分析［J］.临床急诊杂志,2014,15(8):449-451. ［4］Banks PA, Bollen TL, Dervenis C, et al. Classification of acute pancreatitis--2012: revision of the Atlanta classification and definitions by international consensus ［J］. Gut, 2013,62(1):102-111. ［5］TRanieri VM, Rubenfeld GD, et al. Acute respiratory distress syndrome: the Berlin Definition［J］. JAMA, 2012,307(23):2526-2533. DOI:10.1001/jama.2012.5669. ［6］Marshall JC, Cook DJ, Christou NV, et al. Multiple organ dysfunction score:a reliable descript or of a complex clinical outcome ［J］. Critic Care Med, 1995,23(10):1638-1652. ［7］刘松桥,邱海波.急性呼吸窘迫综合征诊治进展［J］. 中华急诊医学杂志,2014,23(3):248-251. ［8］李刚莲,简华刚.ARDS诊断标准和通气策略的进展［J］. 重庆医学,2015,44(32):4592-4594. ［9］Bone RC, Grodzin CJ, Balk RA. Sepsis: anew hypothesis for pathogenesis of the disease process ［J］. Chest, 1997,112(1):235-243. ［10］Thomas M, Moriyama K, Ledebo I. AN69: Evolution of the world’s first high permeability membrane［J］. Contrib Nephrol, 2011,173:119-129. ［11］Herrera-Gutiérrez ME, Seller-Pérez G, Arias-Verdú D, et al. A comparison of the effect of convection against diffusion in hemodynamics and cytokines clearance in an experimental model of septic shock ［J］. J Trauma Acute Care Surg, 2012,73(4):855-860. ［12］Guo J, Huang W, Yang XN, et al. Short-term continuous high-volume hemofiltration on clinical outcomes of severe acute pancreatitis ［J］. Pancreas, 2014,43(2):250-254. ［13］解建,杨君.持续高容量血液滤过对急性呼吸窘迫综合征合并多器官功能障碍综合征患者的治疗作用［J］. 中国危重病急救医学,2009,21(7):402-404. ［14］任宏生,蒋进皎,楚玉峰,等.高容量血液滤过对感染性休克患者血管外肺水和肺泡-动脉间氧交换影响的研究［J］. 中华危重病急救医学,2014,26(9):609-614. ［15］高文英.高容量血液滤过对急性呼吸窘迫综合征患者炎性介质及氧代谢的影响［J］.广东医学,2014,35(21):3384-3387.

相似文献/References:

[1]顾维立,张成亮,徐志华*.晚期糖基化终末产物受体与ARDS患者预后的关系[J].徐州医科大学学报,2018,38(01):33.
　GU Weili,ZHANG Chengliang,XU Zhihua*.The relationship between the receptor for advanced glycation end-products and the prognosis of ARDS patients[J].Journal of Xuzhou Medical University,2018,38(10):33.
[2]赵伟、任泽强.大鼠重症急性胰腺炎胰腺组织中NO生成及iNOS表达的变化[J].徐州医科大学学报,2010,30(10):648.
　[J].Journal of Xuzhou Medical University,2010,30(10):648.
[3]张明珍、阮志群.高容量血液滤过在重症急性胰腺炎治疗中的应用[J].徐州医科大学学报,2010,30(11):779.
　[J].Journal of Xuzhou Medical University,2010,30(10):779.
[4]刘东军、王东、王德书.非手术治疗重症急性胰腺炎66例分析[J].徐州医科大学学报,2001,21(03):231.
　[J].Journal of Xuzhou Medical University,2001,21(10):231.
[5]韩扣兰、邱海波、谭焰等.控制性肺膨胀对急性呼吸窘迫综合征家兔血流动力学和气体交换的影响[J].徐州医科大学学报,2002,22(03):189.
　[J].Journal of Xuzhou Medical University,2002,22(10):189.
[6]提俊响、韩冠杰、李家琼、李茂琴、许铁.气道压力释放通气减轻急性呼吸窘迫综合征肺损伤[J].徐州医科大学学报,2015,35(02):78.
[7]朱湘芸、王洵、赵弘卿.重症病毒性肺炎合并急性呼吸窘迫综合征预后危险因素探讨[J].徐州医科大学学报,2016,36(02):127.
　[J].Journal of Xuzhou Medical University,2016,36(10):127.
[8]惠亮亮、章向成、安旭生、李金芳、减奎、尚福泰、郑崇明、张国新.血清降钙素原及白细胞介素-6对合并急性呼吸窘迫综合征的多器官功能不全患者的临床诊断价值[J].徐州医科大学学报,2016,36(05):296.
　[J].Journal of Xuzhou Medical University,2016,36(10):296.
[9]顾维立、张成亮、徐志华.晚期糖基化终末产物受体与ARDS患者预后的关系[J].徐州医科大学学报,2018,38(01):33.
　[J].Journal of Xuzhou Medical University,2018,38(10):33.
[10]封光、刘海霞、栾秀姝、王天龙.葛根素在内毒素性急性肺损伤中抗炎作用的研究[J].徐州医科大学学报,2019,39(04):235.
　[J].Journal of Xuzhou Medical University,2019,39(10):235.
[11]程书立、许继元、李茂琴等.短时间血液滤过对重症急性胰腺炎并发ARDS的辅助治疗作用[J].徐州医科大学学报,2013,33(05):302.
　[J].Journal of Xuzhou Medical University,2013,33(10):302.
[12]程书立、柳彩侠.早期高容量血液滤过治疗重症急性胰腺炎伴急性呼吸家迫综合征疗效观察[J].徐州医科大学学报,2017,37(10):653.
　[J].Journal of Xuzhou Medical University,2017,37(10):653.

备注/Memo

备注/Memo:
通信作者,E-mail:liucaixiaxz@163.com
更新日期/Last Update: 2017-11-16